Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Categories for... News

News Therapeutic Areas

Sygnature expands capabilities with acquisition of Alderley Oncology

READ ARTICLE

Bioscience Drug Discovery News

Sygnature Discovery expands SPR capacity

READ ARTICLE

News

Sygnature Group adds pharmacology expertise to BD team with recruitment of Dr David Loczenski

READ ARTICLE

News

Sygnature provides equipment to Government’s COVID-19 testing efforts

READ ARTICLE

News

Key Appointments and Retirements at RenaSci

READ ARTICLE

News

COVID-19 – Update

READ ARTICLE

News

COVID-19 and business continuity

READ ARTICLE

News

Sygnature strengthens DMPK team

READ ARTICLE

News

2019 recap!

READ ARTICLE

Awards News

Sygnature Discovery wins Outstanding Achievement Award

READ ARTICLE

News

RenaSci’s Sharon Cheetham awarded BPS Fellowship

READ ARTICLE

News

Sygnature Discovery invests in high-throughput screening capability

READ ARTICLE